Purpose
The intent of the Clinical Pilot and Feasibility Award is to enable investigators to collect sufficient preliminary data to determine the best strategies and methods for approaching a major question that ultimately will require assessment through a larger scale research and/or multi-center, collaborative clinical trial. Support may be requested for $80,000 annually (plus 12 percent for indirect costs) for up to two years.
Background
Extensive survey input from the CF community (people with CF, family members, and caregivers) helped identified key research Areas of Encouragement that are most important to them. The areas selected by the CF community are listed below in order of prioritization. Applications may address any topic area advancing CF care, treatment, or research. However, applications addressing the following areas are particularly encouraged:
- Respiratory microorganism detection and treatment
- Gastrointestinal symptoms (including, but not limited to, gastroesophageal reflux disease (GERD), Distal Intestinal Obstruction Syndrome (DIOS), and pancreatitis)
- Reducing treatment burden
- CF-related diabetes
- Diet and nutrition
- Mental health
- CF-related liver disease
- Exercise
- Sinus disease
- Allergies and asthma in CF
- Alternative/holistic treatments and therapies
- Sexual reproductive health
- Bone/joint health
- Pain management
Key Dates
All letters of intent and full applications must be submitted online at proposalCENTRAL by 5 p.m. ET on the following deadlines.
- Letter of Intent: September 27, 2019
- Full application: February 10, 2020
URL for more information
Filed Under: Funding Opportunities